Sector
PharmaceuticalsOpen
₹2,405Prev. Close
₹2,428.2Turnover(Lac.)
₹409.29Day's High
₹2,443.3Day's Low
₹2,38452 Week's High
₹2,974.9552 Week's Low
₹1,539.95Book Value
₹320.78Face Value
₹8Mkt Cap (₹ Cr.)
3,971.02P/E
34.4EPS
69.88Divi. Yield
0.83Here are some of the stocks that may see significant price movement today: Adani Power & Adani Green, Hindustan Unilever, Dixon Technologies, etc.
Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
---|---|---|---|---|
Equity Capital | 13.23 | 13.23 | 13.23 | 13.23 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 517.3 | 361.62 | 294.37 | 242.54 |
Net Worth | 530.53 | 374.85 | 307.6 | 255.77 |
Minority Interest |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Revenue | 440.16 | 389.14 | 375.57 | 343.95 |
yoy growth (%) | 13.11 | 3.61 | 9.19 | 17.13 |
Raw materials | -141.82 | -131.1 | -127.76 | -114.61 |
As % of sales | 32.22 | 33.68 | 34.01 | 33.32 |
Employee costs | -99.97 | -94.66 | -95.9 | -90.14 |
Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Profit before tax | 73.17 | 53.58 | 41.77 | 20.36 |
Depreciation | -15.66 | -16.47 | -16.36 | -14.34 |
Tax paid | -21.69 | -13.58 | -7.44 | -6.91 |
Working capital | 30 | 44.05 | -12.51 | 19.51 |
Other operating items |
Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 13.11 | 3.61 | 9.19 | 17.13 |
Op profit growth | 23.49 | 18.22 | 57.64 | 35.1 |
EBIT growth | 35.53 | 24.93 | 80.13 | 41.53 |
Net profit growth | 28.7 | 37.88 | 115.68 | -35.98 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,669.8 | 93.52 | 4,00,520.99 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,616 | 79.48 | 1,75,574.28 | 667 | 0.45 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,513.8 | 25.39 | 1,22,186 | 1,485.4 | 1.06 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,321.5 | 20.61 | 1,10,263.53 | 1,200.7 | 0.61 | 5,546.3 | 345.76 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,222.5 | 57.29 | 1,09,167.44 | 474 | 0.99 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman (Non-Executive)
H V Goenka
Company Sec. & Compli. Officer
Rajesh Shirambekar
Independent Director
Sachin Nandgaonkar
Independent Director
Zahabiya Khorakiwala
Independent Director
Bhaskar Vemban Iyer
Non Executive Director
Rajat Bhargava
Independent Director
Hiten Kotak
Independent Director
Anil Matai
Independent Director
RADHIKA GUPTA
Non Executive Director
M K Maheshwari
Non Executive Director
Yugal Sikri
Managing Director
ASHOK NAIR
Non Executive Director
Vasundhara Patni
RPG House,
463 Dr Annie Besant Road Worli,
Maharashtra - 400030
Tel: 91-022-24981650
Website: http://www.rpglifesciences.com
Email: info@rpglifesciences.com
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: www.linkintime.co.in
Email: paytm.ipo@linkintime.co.in
Summary
RPG Life Sciences Limited, formerly Searle India Limited, started in 1968 as a joint venture with GD Searle, USA. In 1993, GD Searle withdrew from India and sold its holdings to RPG Group. The Company...
Read More
Reports by RPG Life Sciences Ltd
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.